FDA approves 23andMe’s genetic testing kit

FDA approves 23andMe’s genetic testing kit

The U.S. Food & Drug Administration (FDA) has finally approved 23andMe’s personal genetic test for certain diseases, including Parkinson’s, Alzheimer’s, and celiac diseases.

The FDA said in statement that the genetic test assess genetic risk for the aforementioned conditions but does not diagnose them. The federal agency also urged people to use their results to help make decisions regarding lifestyle choices and to inform discussions with a healthcare expert.

Jeffrey Shuren, the director of the federal agency’s Center for Devices & Radiological Health, said, “It is important that people understand that genetic risk is just one piece of the bigger puzzle, it does not mean they will or won't ultimately develop a disease.”

The list of other known factors which can play a role in the development of disease includes diet, environment and use of tobacco products.

FDA officials cautioned that genetic risk is merely a piece of information and it doesn’t mean an individual will sooner or later get the disease.

Currently, 23andMe’s personal genetic health risk test costs $199.


Popular Stories

European stocks slide amid U.S.-North Korea tensions

European stocks slipped sharply on Wednesday as... Read More

China’s export-import growth slips

China suffered a minor setback in the growth of its... Read More

Renault signs new JV in Iran

French carmaker Renault has confirmed that it has... Read More

Activist Investor Ackman wants five ADP board seats

After acquiring an 8 per cent stake in Automatic... Read More

Yoga can efficiently ease depression: Research

Yoga can not only efficiently help relax your body... Read More

Facebook preparing to demote slow-loading stories on News Feed

Facebook, the world’s largest social network, is... Read More